Showing results (21-30 of 53) with videos related to
Sort By:
Pageof 6
Frontiers in Oncology|February 7, 2022
PAQR5 Expression Is Suppressed by TGFβ1 and Associated With a Poor Survival Outcome in Renal Clear Cell CarcinomaChang Tao, Wang Liu, Xiang Yan, et al.Protein and Peptide Letters|March 2, 2017
Diosmetin Induces Cell Apoptosis by Regulating CYP1A1/CYP1A2 Due to p53 Activation in HepG2 CellsBin Liu, Kaiqiao Jia, Yu Yang, et al.Biomolecules|September 28, 2021
PAQR6 Upregulation Is Associated with AR Signaling and Unfavorite Prognosis in Prostate CancersMin Yang, Jean Chong Li, Chang Tao, et al.Oncology Letters|September 10, 2014
Dihydromyricetin induces apoptosis and inhibits proliferation in hepatocellular carcinoma cellsJie Liu, Yang Shu, Qingyu Zhang, et al.Protein and Peptide Letters|February 28, 2017
Dihydromyricetin Reduces TGF-β Via P53 Activation-dependent Mechanism in Hepatocellular Carcinoma HepG2 CellsXiaojie Huang, Tianming Lian, Xiaoqian Guan, et al.Molecular Medicine Reports|October 22, 2014
Resveratrol inhibits the proliferation of human melanoma cells by inducing G1/S cell cycle arrest and apoptosisZhiyuan Wu, Bin Liu, Cailing E, et al.Plos One|November 14, 2013
Dihydromyricetin reduced Bcl-2 expression via p53 in human hepatoma HepG2 cellsShixing Wu, Bin Liu, Qingyu Zhang, et al.Protein and Peptide Letters|February 28, 2017
Diosmetin, a Potential p53 Activator, Performs Anticancer Effect by Regulating Cell Cycling and Cell Proliferation in HepG2 CellsBin Liu, Miaomiao Zhang, Shuna Liu, et al.BMC Cancer|July 3, 2019
JS-K, a nitric oxide donor, induces autophagy as a complementary mechanism inhibiting ovarian cancerBin Liu, Xiaojie Huang, Yifang Li, et al.Plos One|April 28, 2015
Dihydromyricetin Enhances the Chemo-Sensitivity of Nedaplatin via Regulation of the p53/Bcl-2 Pathway in Hepatocellular Carcinoma CellsLianggui Jiang, Qingyu Zhang, Hao Ren, et al.Pageof 6